retatrutide causing diarrhea and Diarrhoea: Evidence, Frequency, and Safe Management – Bolt Pharmacy Retatrutide Side Effects: What Patients
Description
The molecule is currently undergoing a Phase 2 clinical study for obesity and type 2 diabetes (NCT05669599), with research findings expected to be updated by the end of 2024
[DOI] [PubMed] [Google Scholar] 31.Adrian TE, et al
Understanding how these medications work is essential for recognising why certain side effects, particularly those affecting the digestive system, may occur during treatment
5 Cholesterol and triglycerides
Hot Picks Today Securities Firms Reverse Course as KOSPI Falls Below 7,000
However, on March 15, 2024, PEIA paused the pilot program due, in part, to the rising cost of GLP-1s
